These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 23723240)

  • 1. Accelerating next-generation vaccine development for global disease prevention.
    Koff WC; Burton DR; Johnson PR; Walker BD; King CR; Nabel GJ; Ahmed R; Bhan MK; Plotkin SA
    Science; 2013 May; 340(6136):1232910. PubMed ID: 23723240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccine adjuvants: current challenges and future approaches.
    Wilson-Welder JH; Torres MP; Kipper MJ; Mallapragada SK; Wannemuehler MJ; Narasimhan B
    J Pharm Sci; 2009 Apr; 98(4):1278-316. PubMed ID: 18704954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological Principles Guiding the Rational Design of Particles for Vaccine Delivery.
    Gause KT; Wheatley AK; Cui J; Yan Y; Kent SJ; Caruso F
    ACS Nano; 2017 Jan; 11(1):54-68. PubMed ID: 28075558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 2020 vision for vaccines against HIV, tuberculosis and malaria.
    Rappuoli R; Aderem A
    Nature; 2011 May; 473(7348):463-9. PubMed ID: 21614073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New approaches in vaccine development.
    Leclerc C
    Comp Immunol Microbiol Infect Dis; 2003 Oct; 26(5-6):329-41. PubMed ID: 12818620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucosal delivery of vaccine antigens and its advantages in pediatrics.
    De Magistris MT
    Adv Drug Deliv Rev; 2006 Apr; 58(1):52-67. PubMed ID: 16516335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-based vaccine design: the promise for malaria and other infectious diseases.
    Doolan DL; Apte SH; Proietti C
    Int J Parasitol; 2014 Oct; 44(12):901-13. PubMed ID: 25196370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The current challenges for vaccine development.
    Oyston P; Robinson K
    J Med Microbiol; 2012 Jul; 61(Pt 7):889-894. PubMed ID: 22322337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Approaches to new vaccines.
    Mahon BP; Moore A; Johnson PA; Mills KH
    Crit Rev Biotechnol; 1998; 18(4):257-82. PubMed ID: 9887505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Research priorities for vaccines to be used at a global level.
    Lambert PH
    Behring Inst Mitt; 1994 Dec; (95):1-6. PubMed ID: 7755502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From vaccine practice to vaccine science: the contribution of human immunology to the prevention of infectious disease.
    Mortellaro A; Ricciardi-Castagnoli P
    Immunol Cell Biol; 2011 Mar; 89(3):332-9. PubMed ID: 21301476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccine technologies: From whole organisms to rationally designed protein assemblies.
    Karch CP; Burkhard P
    Biochem Pharmacol; 2016 Nov; 120():1-14. PubMed ID: 27157411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine adjuvants: smart components to boost the immune system.
    Bastola R; Noh G; Keum T; Bashyal S; Seo JE; Choi J; Oh Y; Cho Y; Lee S
    Arch Pharm Res; 2017 Nov; 40(11):1238-1248. PubMed ID: 29027637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in vaccine adjuvants.
    Singh M; O'Hagan DT
    Pharm Res; 2002 Jun; 19(6):715-28. PubMed ID: 12134940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. mRNA vaccines: a new opportunity for malaria, tuberculosis and HIV.
    Matarazzo L; Bettencourt PJG
    Front Immunol; 2023; 14():1172691. PubMed ID: 37168860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational application of nanoadjuvant for mucosal vaccine delivery system.
    Dewangan HK
    J Immunol Methods; 2020; 481-482():112791. PubMed ID: 32387695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospects for vaccines to protect against AIDS, tuberculosis, and malaria.
    Letvin NL; Bloom BR; Hoffman SL
    JAMA; 2001 Feb; 285(5):606-11. PubMed ID: 11176867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving vaccine performance with adjuvants.
    Vogel FR
    Clin Infect Dis; 2000 Jun; 30 Suppl 3():S266-70. PubMed ID: 10875797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defending the mucosa: adjuvant and carrier formulations for mucosal immunity.
    Lawson LB; Norton EB; Clements JD
    Curr Opin Immunol; 2011 Jun; 23(3):414-20. PubMed ID: 21511452
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 23.